Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion
about
Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutininsComplex networks govern coiled-coil oligomerization--predicting and profiling by means of a machine learning approachAntibody recognition of a highly conserved influenza virus epitopeRecent progress in structure-based anti-influenza drug designA new in vitro hemagglutinin inhibitor screening system based on a single-vesicle fusion assay.Binding of a potent small-molecule inhibitor of six-helix bundle formation requires interactions with both heptad-repeats of the RSV fusion proteinStructures of Receptor Complexes of a North American H7N2 Influenza Hemagglutinin with a Loop Deletion in the Receptor Binding SiteA neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutininsInsights into Avian Influenza Virus Pathogenicity: the Hemagglutinin Precursor HA0 of Subtype H16 Has an Alpha-Helix Structure in Its Cleavage Site with Inefficient HA1/HA2 CleavageStructural vaccinology: structure-based design of influenza A virus hemagglutinin subtype-specific subunit vaccinesStructure and Receptor Binding Specificity of Hemagglutinin H13 from Avian Influenza A Virus H13N6Structure and Receptor Complexes of the Hemagglutinin from a Highly Pathogenic H7N7 Influenza VirusStructural Analysis of the Hemagglutinin from the Recent 2013 H7N9 Influenza VirusCompounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virusCompounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part I: Influenza life-cycle and currently available drugsInhibition of influenza A virus (H1N1) fusion by benzenesulfonamide derivatives targeting viral hemagglutininInhibition of influenza H7 hemagglutinin-mediated entryCharacterization of potent fusion inhibitors of influenza virusIdentification and Characterization of Influenza Virus Entry Inhibitors through Dual Myxovirus High-Throughput ScreeningNew small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusionH1N1, but not H3N2, influenza A virus infection protects ferrets from H5N1 encephalitis.Continuing challenges in influenza.Mutagenesis studies of the H5 influenza hemagglutinin stem loop region.The breadth of cross sub-type neutralisation activity of a single domain antibody to influenza hemagglutinin can be increased by antibody valency.The hemagglutinin of the influenza A(H1N1)pdm09 is mutating towards stability.Seasonal influenza vaccination is the strongest correlate of cross-reactive antibody responses in migratory bird handlers.Molecular epidemiology of influenza A virus infection among hospitalized children in Vietnam during post-pandemic period.A Potent Anti-influenza Compound Blocks Fusion through Stabilization of the Prefusion Conformation of the Hemagglutinin ProteinEmerging antiviral targets for influenza A virus.Molecular Characterizations of Surface Proteins Hemagglutinin and Neuraminidase from Recent H5Nx Avian Influenza Viruses.Structures of influenza A proteins and insights into antiviral drug targets.Perspectives on influenza evolution and the role of research.In silico characterization of the functional and structural modules of the hemagglutinin protein from the swine-origin influenza virus A (H1N1)-2009.Computational approach for predicting the conserved B-cell epitopes of hemagglutinin H7 subtype influenza virus.Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol.Structural basis and sequence co-evolution analysis of the hemagglutinin protein of pandemic influenza A/H1N1 (2009) virus.Molecular-level simulation of pandemic influenza glycoproteins.Free-energy simulations reveal that both hydrophobic and polar interactions are important for influenza hemagglutinin antibody binding.Paramagnetic particles coupled with an automated flow injection analysis as a tool for influenza viral protein detection.Emerging antiviral strategies to interfere with influenza virus entry.
P2860
Q21131563-D5443FCA-6C70-48B0-B1BE-AA35806010C3Q24632790-6CD5888E-ECEA-4670-A1CE-62CD0FE344C4Q24655932-FF0E8F6F-3CD1-4D3C-A6CC-62EA8384AE02Q26863710-F1F53B27-06DB-44A5-96FD-72D8B3C83553Q27321534-0111529D-6641-45C7-BE11-13622B42ACD0Q27658463-E2869737-5DB9-4778-BB0B-FCE09AAB00BCQ27664346-2243585A-5B5B-4845-9006-D0C0645C7863Q27671165-D1EBD2CB-466E-4585-BF52-25402ED56657Q27673446-1E2BE30B-F53B-4DAD-9714-33234B9D01ECQ27676658-3C10FC64-E930-4D18-B76E-5CB9C4D28BBEQ27678588-E62EE3CD-78E2-4366-BCED-56FBFEFC60BAQ27679529-4CB360FA-7EB0-4D2E-BACB-4A98B5D825B4Q27679929-91D0A92E-A3BE-4157-A8E1-D1A674A46CBCQ28084005-084DF3F4-69C7-44DB-BC86-CB2E1DFE804CQ28085400-AD9E7FA3-5E2B-4F83-B9E2-FB076AF74C58Q28478448-B1C14574-4790-4B4A-9F4F-51F923530052Q28534616-D7394E97-2973-4F8E-8AAF-F3F0A443F6A8Q28544971-C2349945-FFE3-47C7-8306-897BCC5A91E5Q28830304-4A762EA7-E9A1-49B1-B20F-B488F6ADBEB3Q30355297-B8B0725F-A9A9-4677-AF0C-26E096A2328CQ30357273-1189D6C7-5319-4FA4-88EC-FA998875FD1FQ30363190-05F36790-C0C5-4253-A016-EE01EEE8CB64Q30363789-3BB75C82-2E44-4456-B3D7-AB0669E8A21FQ30365366-04FE632A-682C-47E2-839D-98873D5B15D3Q30367928-4C050302-1AF4-4D98-B40E-2530C0FB4920Q30369530-10EE2314-0187-42F5-8EA2-AB913A8E3C48Q30371406-AB826149-8FD4-4D8E-B15C-509951895041Q30374768-12DE17DB-0865-4B68-878A-103F62ABCC51Q30376907-A3D0AE28-18C8-4710-ADD9-F8AA06650CDAQ30386603-4CA30D61-69F4-4574-B621-302780485FF8Q30387969-1C01B84F-9BF2-4C14-9650-AAEA02CE1CE3Q30390922-6CA02C12-97D4-4FD3-A9F5-C1D31F8F7DB5Q30391096-DC3401A4-C0ED-4D96-9503-90D41B20D59EQ30393728-02CDE569-03DB-491B-B3AF-F7E364452360Q30396717-48657243-B95C-4BD5-AABF-7430AD1CF2E7Q30404465-12D5B8E9-C7CE-4110-814D-06658A970480Q30410858-ABC8F67F-69DB-4EF2-99B2-893C3157FB83Q30414700-734E663A-DC97-4C2A-A2DE-1D545D4F317AQ30420967-BD228A9B-729D-422E-84BC-D15485C0DA40Q30432421-1DFD2757-5F48-4678-A693-E014A8356B54
P2860
Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion
@ast
Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion
@en
Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion
@nl
type
label
Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion
@ast
Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion
@en
Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion
@nl
prefLabel
Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion
@ast
Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion
@en
Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion
@nl
P2093
P2860
P3181
P356
P1476
Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion
@en
P2093
David A Steinhauer
David J Stevens
John J Skehel
Philip S Kerry
Rupert J Russell
Stephen R Martin
Steven J Gamblin
P2860
P304
P3181
P356
10.1073/PNAS.0807142105
P407
P577
2008-11-18T00:00:00Z